NewtekOne, Inc. logo NEWT - NewtekOne, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 1
HOLD 8
SELL 0
STRONG
SELL
0
| PRICE TARGET: $14.00 DETAILS
HIGH: $14.00
LOW: $14.00
MEDIAN: $14.00
CONSENSUS: $14.00
DOWNSIDE: 10.03%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 90% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Strong
Trading 41.5% below fair value
Current Price $15.56
Bear Case $18.62 19.7% upside ($18.62 - $15.56) / $15.56 = 19.7% ROTCE 11.9% → 1.01x TBV
Fair Value $26.61 71.0% upside ($26.61 - $15.56) / $15.56 = 71.0% ROTCE 15.8% → 1.52x TBV
Bull Case $34.59 122.3% upside ($34.59 - $15.56) / $15.56 = 122.3% ROTCE 18.2% → 1.83x TBV

Adjust Assumptions

15.8%
11.7%

Key Value Driver

ROTCE (15.8%) vs. cost of equity (11.7%)

Implied Market Multiple 1.17x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $14.00 from 9 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $26.61 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $14.00 (from 9 analysts). Our estimate is 113% above the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly